Last10K.com

Amyris, Inc. (AMRS) SEC Filing 10-Q Quarterly report for the period ending Tuesday, June 30, 2020

Amyris, Inc.

CIK: 1365916 Ticker: AMRS

image01.jpg      



FOR IMMEDIATE RELEASE

Investor Contact
Peter DeNardo  
Amyris, Inc.
+1 (510) 597-5592  
denardo@amryis.com

AMYRIS, INC. REPORTS
SECOND QUARTER 2020 RESULTS

Record Quarter for Consumer Brands with 3X Revenue Growth

Lowest Cash Operating Expenses in Five Quarters

$200 Million Private Placement Significantly Reduced Debt and Debt Servicing Expense


EMERYVILLE, CA – August 6, 2020
–  Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced financial results for its second quarter ended June 30, 2020.

Highlights
Completed $200 million private placement during Q2; largest raise in the history of the company
Reduced debt by $121 million or 40% since start of 2020. Improves H2 2020 debt servicing cash costs by $30 million
Q2 Recurring Revenue for Consumer & Ingredients of $26 million more than doubled YOY. Record quarter for Consumer brands with revenue tripling YOY from strong online sales
Cash Operating Expenses of $43 million were the lowest in the five sequential quarters and down 6% versus prior year. Lower G&A and R&D expense was partly reinvested in consumer brands
Signed commercial partnership for Purecane™ in commercial baking applications with AB Mauri
Signed term sheet for a scientific partnership with Infectious Disease Research Institute (IDRI) to create RNA vaccine platform

Management Comments
“Our business and our people have shown strong resilience during these unprecedented times. Keeping everyone safe has been our number one priority while continuing to grow revenue and improve operations. COVID has certainly had an impact in how we operate the business. For example, COVID has impacted progress with third party manufacturing,” said John Melo, President and Chief Executive Officer. “Lower consumer revenue from store closures was mitigated by consumers transitioning online. Our consumer brands saw record revenue in the quarter and, for the


The following information was filed by Amyris, Inc. (AMRS) on Thursday, August 6, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Amyris, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Amyris, Inc..

Continue

Assess how Amyris, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Amyris, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Other
Filter Subcategory:
All
Expense
Product
Cash Flow
Shares
Debt
Earnings
Geography
Other
Inside Amyris, Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover Page
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parentheticals)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Comprehensive Loss
Condensed Consolidated Statements Of Operations
Condensed Consolidated Statements Of Operations (Parentheticals)
Consolidated Statements Of Stockholders' Deficit And Mezzanine Equity
Balance Sheet Details
Balance Sheet Details (Tables)
Balance Sheet Details - Accrued And Other Current Liabilities (Details)
Balance Sheet Details - Additional Information (Details)
Balance Sheet Details - Allowance For Doubtful Accounts (Details)
Balance Sheet Details - Deferred Cost Of Products Sold - Related Party (Details)
Balance Sheet Details - Depreciation And Amortization (Details)
Balance Sheet Details - Inventories (Details)
Balance Sheet Details - Maturities Of Financing And Operating Leases (Details)
Balance Sheet Details - Other Assets (Details)
Balance Sheet Details - Other Noncurrent Liabilities (Details)
Balance Sheet Details - Prepaid Expenses And Other Current Assets (Details)
Balance Sheet Details - Property, Plant And Equipment (Details)
Balance Sheet Details - Right-Of-Use Assets And Related Lease Liabilities (Details)
Basis Of Presentation And Summary Of Significant Accounting Policies
Basis Of Presentation And Summary Of Significant Accounting Policies (Details)
Basis Of Presentation And Summary Of Significant Accounting Policies (Policies)
Commitments And Contingencies
Debt
Debt (Tables)
Debt - 2014 Rule 144A Note Exchange And Extension - Total, Related Party (Details)
Debt - Amendment No. 1 To Foris Lsa ??? Foris, Related Party (Details)
Debt - Amendment To Senior Convertible Notes Due 2022 (Details)
Debt - Debt Components (Details)
Debt - Debt Equitization - Foris Related Party (Details)
Debt - Exchange Of Senior Convertible Notes Due 2022 (Details)
Debt - Foris $5 Million Note ??? Foris, Related Party (Details)
Debt - Future Minimum Payments (Details)
Debt - Ginkgo Waiver Agreement (Details)
Debt - Nikko Secured Loan Agreement Amendment (Details)
Debt - Paycheck Protection Plan Loan (Details)
Debt - Schottenfeld Forbearance Agreement (Details)
Fair Value Measurement
Fair Value Measurement (Tables)
Fair Value Measurement - Bifurcated Embedded Features In Debt Instruments (Details)
Fair Value Measurement - Fair Value Of Debt ??? Foris Convertible Note (Lsa Amendment) (Details)
Fair Value Measurement - Fair Value Of Debt ??? Senior Convertible Notes (Details)
Fair Value Measurement - Fair Value, Assets, And Liabilities Measured On Recurring Basis (Details)
Fair Value Measurement - Fair Value, Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation (Details)
Fair Value Measurement - Financial Assets And Liabilities (Details)
Fair Value Measurement - Freestanding Derivative Instruments (Details)
Fair Value Measurement - Market-Based Assumption And Estimates For Compound Embedded Derivative Liabilities Valuation (Details)
Fair Value Measurement - Reconciliation For Compound Embedded Derivative Liability (Details)
Loss Per Share
Loss Per Share (Tables)
Loss Per Share - Antidilutive Securities Excluded From Computation Of Earnings Per Share (Details)
Loss Per Share - Calculation Of Basic And Diluted Net Loss Per Share Of Common Stock (Details)
Mezzanine Equity
Mezzanine Equity (Details Textual)
Related Party Transactions
Related Party Transactions (Tables)
Related Party Transactions - Additional Information (Details)
Related Party Transactions - Related Party Accounts Receivable (Details)
Related Party Transactions - Related Party Debt (Details)
Revenue Recognition And Contact Assets And Liabilities - Narrative (Details)
Revenue Recognition And Contract Assets And Liabilities
Revenue Recognition And Contract Assets And Liabilities (Tables)
Revenue Recognition And Contract Assets And Liabilities - Contract Balances (Details)
Revenue Recognition And Contract Assets And Liabilities - Disaggregation Of Revenue (Details)
Revenue Recognition And Contract Assets And Liabilities - Remaining Performance Obligations (Details)
Revenue Recognition And Contract Assets And Liabilities - Revenue In Connection With Significant Revenue Agreement (Details)
Stock-Based Compensation
Stock-Based Compensation (Tables)
Stock-Based Compensation - Additional Information (Details)
Stock-Based Compensation - Employee Service Share-Based Compensation, Allocation Of Recognized Period Costs (Details)
Stock-Based Compensation - Share-Based Compensation, Stock Options And Stock Appreciation Rights Award Activity (Details)
Stock-Based Compensation - Temporal Display Of Share-Based Compensation, Restricted Stock And Restricted Stock Units Activity (Details)
Stockholders' Deficit
Stockholders' Deficit (Tables)
Stockholders' Deficit - Foris Warrant Exercises For Cash (Details)
Stockholders' Deficit - Increase In Authorized Common Stock (Details)
Stockholders' Deficit - January 2020 Private Placement (Details)
Stockholders' Deficit - January 2020 Warrant Amendments And Exercises, Foris Debt Equitization And Private Placement (Details)
Stockholders' Deficit - June 2020 Pipe (Details)
Stockholders' Deficit - Release Of Pre-Delivery Shares And Amendment To Warrants Issued To Holders Of Senior Convertible Notes Due 2022 (Details)
Stockholders' Deficit - Series E Convertible Preferred Stock And Amendment To Articles Of Incorporation Or Bylaws (Details)
Stockholders' Deficit - Total Conversion Price Reduction And Subsequent Conversion Into Common Stock (Details)
Stockholders' Deficit - Warrant Activity (Details)
Stockholders' Deficit - Warrant Amendments And Exercise By Certain Holders (Details)
Stockholders' Deficit - Warrant Amendments And Exercises, Common Stock Purchase And Debt Equitization By Foris- Related Party (Details)
Subsequent Events
Subsequent Events (Details)
Ticker: AMRS
CIK: 1365916
Form Type: 10-Q Quarterly Report
Accession Number: 0001365916-20-000150
Submitted to the SEC: Mon Aug 10 2020 5:29:50 PM EST
Accepted by the SEC: Mon Aug 10 2020
Period: Tuesday, June 30, 2020
Industry: Industrial Organic Chemicals

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/amrs/0001365916-20-000150.htm